Your patient is deciding whether to enroll in a clinical trial at your institution and wants your advice about whether to participate.
Search results for: methotrexate
The Mystery of IVIg
Although initially given as replacement therapy for patients with primary and secondary immunodeficiency states, intravenous immunoglobulin (IVIg) has proven to be effective in the treatment of various autoimmune and inflammatory disorders. This success has led to a dramatic increase in the use of IVIg, with its use as an antiinflammatory agent now vastly surpassing its use in the treatment of immunodeficiencies. Even so, the basis for the antiinflammatory activity of IVIg remains unclear.
Where Will Kinase Inhibitors Fit into the RA Treatment Mix?
Presenters at “Looking Ahead to Kinase Inhibition in Rheumatoid Arthritis,” a session here at the 2011 ACR/ARHP Annual Scientific Meeting, delved into some of the big questions that rheumatology faces with kinase inhibitor use.
Susac’s Syndrome: Confusion, Expressive Aphasia, Gait Instability
A 49-year-old man presented to the hospital with confusion, dysarthria, expressive aphasia, and progressive gait instability.
Information on New Drug Approvals and Medication Safety
Rheumatology-related drug safety, approvals, and what’s in the pipeline.
A Patient’s Perspective on RA
I was diagnosed in April 2010, at 44 years old, with seropositive RA; the disease rapidly turned my life upside down.
ACR Honors Contributions to Rheumatology
Rheumatologists recognized for their work in the field
A Short History of Rheumatoid Arthritis Therapeutics
Or, why I chose to become a rheumatologist
Drug Updates: Apremilast, Belimumab, and More
Information on new approvals and medication safety
The Science of MDHAQ/RAPID3 Scores
Do patient self-reports provide valid data for evidence-based care in rheumatology practice?
- « Previous Page
- 1
- …
- 86
- 87
- 88
- 89
- 90
- …
- 101
- Next Page »